Versant Venture Management as of March 31, 2017
Portfolio Holdings for Versant Venture Management
Versant Venture Management holds 8 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Achaogen | 23.5 | $32M | 1.3M | 25.23 | |
| Audentes Therapeutics | 22.4 | $31M | 1.8M | 17.04 | |
| Clovis Oncology | 18.9 | $26M | 407k | 63.67 | |
| Ocular Therapeutix (OCUL) | 14.9 | $21M | 2.2M | 9.28 | |
| Immune Design | 10.9 | $15M | 2.2M | 6.80 | |
| Second Sight Med Prods | 4.0 | $5.4M | 4.5M | 1.21 | |
| Cymabay Therapeutics | 3.3 | $4.5M | 1.0M | 4.30 | |
| Opgen | 2.1 | $2.9M | 2.6M | 1.15 |
